Experimental TLR4 inhibition improves intestinal microcirculation in endotoxemic rats

The TLR4 pathway may be a target in clinical Gram-negative sepsis since administration of the TLR4 antagonist CRX-526 improved intestinal microcirculation parameters in experimental endotoxemia.